{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:41:11Z","timestamp":1790347271347,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.mehy.2019.109371","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T11:39:16Z","timestamp":1566214756000},"page":"109371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-\u03baB signaling"],"prefix":"10.1016","volume":"133","author":[{"given":"Fatemeh","family":"Majdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Motaghinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08897070802218554","article-title":"Pharmacotherapy of methamphetamine addiction: an update","volume":"29","author":"Elkashef","year":"2008","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10401230802177656","article-title":"Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions","volume":"20","author":"Rose","year":"2008","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADT.0000000000000059","article-title":"Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction","volume":"15","author":"Ellis","year":"2016","journal-title":"Addictive Disorders Their Treatment"},{"key":"10.1016\/j.mehy.2019.109371_b0020","article-title":"Duloxetine by Modulating the Akt\/GSK3 Signaling Pathways Has Neuroprotective Effects against Methamphetamine-Induced Neurodegeneration and Cognition Impairment in Rats","author":"Borumand","year":"2018","journal-title":"Iranian J Med Sci"},{"key":"10.1016\/j.mehy.2019.109371_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.addbeh.2014.08.007","article-title":"Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders","volume":"40","author":"Casaletto","year":"2015","journal-title":"Addict Behav"},{"issue":"4","key":"10.1016\/j.mehy.2019.109371_b0030","first-page":"206","article-title":"Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats","volume":"9","author":"Ramshini","year":"2018","journal-title":"Addiction Health"},{"issue":"4","key":"10.1016\/j.mehy.2019.109371_b0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12272-017-0897-y","article-title":"Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors","volume":"40","author":"Shin","year":"2017","journal-title":"Arch Pharmacal Res"},{"key":"10.1016\/j.mehy.2019.109371_b0040","first-page":"1","volume":"2018","year":"2018","journal-title":"Oxid Med Cell Longevity"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11064-017-2318-5","article-title":"Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis\u2014A Review","volume":"43","author":"Shin","year":"2018","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2019.109371_b0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2016.05.049","article-title":"Melatonin promotes blood-brain barrier integrity in methamphetamine-induced inflammation in primary rat brain microvascular endothelial cells","volume":"1646","author":"Jumnongprakhon","year":"2016","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12865-016-0145-0","article-title":"Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets","volume":"17","author":"Najera","year":"2016","journal-title":"BMC Immunol"},{"key":"10.1016\/j.mehy.2019.109371_b0060","article-title":"Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway","volume":"1\u201316","author":"Sharikova","year":"2018","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.mehy.2019.109371_b0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fnmol.2017.00409","article-title":"Toll-like receptor 4 mediates methamphetamine-induced neuroinflammation through caspase-11 signaling pathway in astrocytes","volume":"10","author":"Du","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"14","key":"10.1016\/j.mehy.2019.109371_b0070","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1073\/pnas.1432609100","article-title":"Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway","volume":"100","author":"Lehnardt","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.mehy.2019.109371_b0075","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.4268-04.2005","article-title":"Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines","volume":"25","author":"Chakravarty","year":"2005","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.mehy.2019.109371_b0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1600-0854.2009.00899.x","article-title":"How location governs Toll-like receptor signaling","volume":"10","author":"Chaturvedi","year":"2009","journal-title":"Traffic"},{"issue":"7","key":"10.1016\/j.mehy.2019.109371_b0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"5625","key":"10.1016\/j.mehy.2019.109371_b0090","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1085536","article-title":"Toll-like receptor signaling pathways","volume":"300","author":"Barton","year":"2003","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mehy.2019.109371_b0095","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4\u2013dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"issue":"6857","key":"10.1016\/j.mehy.2019.109371_b0100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-\u03baB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2019.109371_b0105","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4049\/jimmunol.172.4.2522","article-title":"Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-\u03baB","volume":"172","author":"Asehnoune","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of Toll-like receptor signals in innate immune defence","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"6851","key":"10.1016\/j.mehy.2019.109371_b0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.mehy.2019.109371_b0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.mehy.2019.109371_b0125","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ni986","article-title":"TRAM is specifically involved in the Toll-like receptor 4\u2013mediated MyD88-independent signaling pathway","volume":"4","author":"Yamamoto","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/JCI11837","article-title":"Toll-like receptor\u2013mediated NF-\u03baB activation: a phylogenetically conserved paradigm in innate immunity","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.ATV.0000251608.09329.9a","article-title":"Role of the Toll-like receptor 4\/NF-\u03baB pathway in saturated fatty acid\u2013induced inflammatory changes in the interaction between adipocytes and macrophages","volume":"27","author":"Suganami","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.mehy.2019.109371_b0140","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2013recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"issue":"14","key":"10.1016\/j.mehy.2019.109371_b0145","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212) \u03949-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2019.109371_b0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/NMM:7:1-2:037","article-title":"Cannabinoid receptors and their role in neuroprotection","volume":"7","author":"Van der Stelt","year":"2005","journal-title":"NeuroMol Med"},{"key":"10.1016\/j.mehy.2019.109371_b0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.mehy.2019.109371_b0165","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.mehy.2019.109371_b0170","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects","volume":"115","author":"Jiang","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.mehy.2019.109371_b0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuropharm.2012.05.039","article-title":"A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers","volume":"64","author":"de Bitencourt","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.mehy.2019.109371_b0180","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12031-015-0703-6","article-title":"Cannabidiol post-treatment alleviates rat epileptic-related behaviors and activates hippocampal cell autophagy pathway along with antioxidant defense in chronic phase of pilocarpine-induced seizure","volume":"58","author":"Hosseinzadeh","year":"2016","journal-title":"J Mol Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol\u2014transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2003","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00210-004-0871-3","article-title":"Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw","volume":"369","author":"Costa","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109371_b0195","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radical Biol Med"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2019.109371_b0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2019.109371_b0205","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","author":"Mecha","year":"201236","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2019.109371_b0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in \u03b2-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-\u03baB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on \u03b2-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2119\/molmed.2014.00261","article-title":"Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis","volume":"21","author":"Hao","year":"2015","journal-title":"Mol Med"},{"issue":"29","key":"10.1016\/j.mehy.2019.109371_b0225","doi-asserted-by":"crossref","first-page":"46603","DOI":"10.18632\/oncotarget.10314","article-title":"Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis","volume":"7","author":"Zeissler","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.mehy.2019.109371_b0230","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1254\/jphs.FMJ04003X2","volume":"96","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.mehy.2019.109371_b0235","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuropharm.2016.04.009","article-title":"Toll-like receptor signalling as a cannabinoid target in multiple sclerosis","volume":"113","author":"Fitzpatrick","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2019.109371_b0240","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5831315","article-title":"Interaction between cannabinoid system and toll-like receptors controls inflammation","volume":"2016","author":"McCoy","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0245","first-page":"305","article-title":"Pharmacological treatments for methamphetamine addiction: current status and future directions","volume":"10","author":"Ballester","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2014.05.001","article-title":"Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia","volume":"144","author":"Matsumoto","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mehy.2019.109371_b0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/187231280702140520191324","article-title":"Oxidative stress and lipid peroxidation in prolonged users of methamphetamine","volume":"7","author":"Solhi","year":"2013","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.mehy.2019.109371_b0260","article-title":"N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells","author":"Chandramani Shivalingappa","year":"20122012","journal-title":"Parkinson\u2019s Disease"},{"key":"10.1016\/j.mehy.2019.109371_b0265","article-title":"Chlorogenic and caftaric acids in liver toxicity and oxidative stress induced by methamphetamine","author":"Koriem","year":"20142014","journal-title":"J Toxicol"},{"key":"10.1016\/j.mehy.2019.109371_b0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuro.2013.05.009","article-title":"Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium","volume":"37","author":"Barayuga","year":"2013","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0275","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0971-6580.172250","article-title":"Protective effects of propofol against methamphetamine-induced neurotoxicity","volume":"22","author":"Shokrzadeh","year":"2015","journal-title":"Toxicol Int"},{"issue":"6","key":"10.1016\/j.mehy.2019.109371_b0280","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.biopha.2014.06.001","article-title":"Glutathione and redox signaling in substance abuse","volume":"68","author":"Uys","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2019.109371_b0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2014.01.032","article-title":"Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine","volume":"727","author":"Downey","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109371_b0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1460-9568.2009.07059.x","article-title":"Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin","volume":"31","author":"Gon\u00e7alves","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2019.109371_b0295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109371_b0300","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/bst0280563","volume":"28","year":"2000","journal-title":"Biochm Soc Trans"},{"issue":"2","key":"10.1016\/j.mehy.2019.109371_b0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S0007114511002868","article-title":"Saturated fatty acids activate microglia via Toll-like receptor 4\/NF-\u03baB signalling","volume":"107","author":"Wang","year":"2012","journal-title":"Br J Nutr"},{"issue":"33","key":"10.1016\/j.mehy.2019.109371_b0310","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0315","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12035-013-8425-7","article-title":"Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway","volume":"48","author":"Lucas","year":"2013","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12974-018-1130-8","article-title":"Toll-like receptor 3 modulates the behavioral effects of cocaine in mice","volume":"15","author":"Zhu","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.mehy.2019.109371_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098079","article-title":"\u03949-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity","volume":"9","author":"Castelli","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.mehy.2019.109371_b0330","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)63558-4","article-title":"Neuroprotective effect of (\u2212) \u03949-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite","volume":"163","author":"El-Remessy","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2019.109371_b0335","doi-asserted-by":"crossref","first-page":"S25081","DOI":"10.4137\/SART.S25081","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Substance abuse: research and treatment","volume":"9","author":"Prud'homme","year":"2015","journal-title":"SART"},{"issue":"12","key":"10.1016\/j.mehy.2019.109371_b0340","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats","volume":"32","author":"Hay","year":"2018","journal-title":"J Psychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2019.109371_b0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10681-004-4756-9","article-title":"Pharmacological and therapeutic targets for \u0394 9 tetrahydrocannabinol and cannabidiol","volume":"140","author":"Pertwee","year":"2004","journal-title":"Euphytica"},{"issue":"2","key":"10.1016\/j.mehy.2019.109371_b0350","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.mehy.2019.109371_b0355","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1124\/dmd.108.020909","article-title":"Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis","volume":"36","author":"Takeda","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.mehy.2019.109371_b0360","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-3565(24)39301-2","article-title":"Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism","volume":"293","author":"Chen","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.mehy.2019.109371_b0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci Ther"},{"issue":"8","key":"10.1016\/j.mehy.2019.109371_b0370","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0006-2952(96)00480-7","article-title":"Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression","volume":"52","author":"Kaminski","year":"1996","journal-title":"Biochem Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771930739X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771930739X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:16:38Z","timestamp":1759691798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771930739X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":74,"alternative-id":["S030698771930739X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109371","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109371"}}